Author

S. Bedard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Desroches· 1 shared A. Rendina· 1 shared A. Rutkowska· 1 shared C. F. Bentzinger· 1 shared C. Zhang· 1 shared D. Favre· 1 shared D. Taylor· 1 shared D. Thomson· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Desroches

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Apelin Stimulation of the Perivascular MuSC Niche Enhances Endogenous Repair in Muscular Dystrophy

E. Le Moal, Y. Liu, J. Collerette-Tremblay, S. Dumontier, J. Boutin, J. Dort, Z. Orfi, J. Michaud, H. Giguere, A. Desroches, F. Vezina, S. Bedard, F. Balg, P. Sarret, M. S. Scott, , C. F. Bentzinger

This study shows that apelin-13 enhances muscle regeneration in dystrophic mice by stimulating endothelial cells in the perivascular niche, improving MuSC function and tissue repair.

bioRxiv · Sep 9, 2022Cell Biology

Normalizing automatic spinal cord cross-sectional area measures

S. Bedard, J. Cohen-Adad

This study develops a normalization model for spinal cord cross-sectional area (CSA) using a PMJ-based reference, reducing inter-subject variability in a large cohort.

bioRxiv · Sep 30, 2021 · PreprintBioengineering

Characterization of apo-form selective inhibition of indoleamine 2,3-dioxygenase.

R. F. Ortiz-Meoz, L. Wang, R. Matico, A. Rutkowska, M. De la Rosa, S. Bedard, R. Midgett, K. Strohmer, D. Thomson, C. Zhang, M. Mebrahtu, J. Guss, R. Totoritis, T. Consler, N. Campobasso, , G. Zhang

This study compares two IDO1 inhibitors, showing GSK5628 selectively inhibits apo-IDO1 by competing with heme, while epacadostat binds to the heme cofactor, leading to longer-lasting inhibition.

bioRxiv · May 7, 2020Biochemistry